EligibleTrials

Adaptive Stereotactic Radiotherapy for Localized Prostate Cancer

Recruiting · NCT07344844 · Interventional (participants receive a specific treatment) · Lead sponsor: Clinique Sainte Clotilde

View the official record on ClinicalTrials.gov →
Prostate cancer

Interventions studied

Low-dose CT imaging before each SBRT session

What this trial is about

This study evaluates whether adaptive stereotactic body radiotherapy (SBRT) provides dosimetric advantages compared to non-adaptive SBRT in localized prostate cancer. Five low-dose CT scans are performed before each SBRT session to assess anatomical variations (bladder filling, rectal volume) and determine if a dosimetric recalculation would have been required. The study also evaluates cumulative dose to organs at risk, patient-reported quality of life over 24 months, and overall and recurrence-free survival.

Who can take part

Age range
60 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.